Thomas Miller
Nessuna posizione attualmente
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Walker H. Colston | M | 63 | 21 anni | |
| Chris Williams | M | 62 | 16 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Victor Alston | M | 52 | 8 anni | |
| Alfred Mann | M | 98 | 18 anni | |
| Atul Bhatnagar | M | 66 | 5 anni | |
| Matthew Pfeffer | M | 67 | - | |
| Jonathan McGuire | M | 61 | - | |
| Anne-Marie Ripley | F | 54 | 11 anni | |
| Maik Lankau | M | - | - | |
| Laurent Asscher | M | 53 | 9 anni | |
| Gail Hamilton | F | 74 | 12 anni | |
| Jonathan Fram | M | 66 | 12 anni | |
| Stephen Okland | M | 60 | - | |
| Jon F. Rager | M | 84 | 16 anni | |
| Tim Jones | M | - | - | |
| Jim R. Smith | M | - | - | |
| Brent Novak | M | 51 | 14 anni | |
| Brian V. Mech | M | 55 | 16 anni | |
| Patti Key | F | - | - | |
| Anupam Sahai | M | - | - | |
| Raymond de Graaf | M | 57 | 7 anni | |
| James Miller | M | - | - | |
| Bob Holmen | M | 60 |
CoCensys, Inc.
 CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 2 anni |
| Alan Grahame | M | 71 | 8 anni | |
| Doug Samuelson | M | 64 | 4 anni | |
| John Moses | M | 65 | 1 anni | |
| Cliff Hannel | M | 61 | - | |
| David Edward Anderson | M | 68 | 6 anni | |
| Robert W. Bass | M | 77 | 7 anni | |
| Lowell E. Sears | M | 73 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 4 anni |
| Alexander Pepe | M | 61 | - | |
| Massoud Entekhabi | M | 70 | - | |
| Alan Cuellar Amrod | M | 65 | - | |
| David Jacques | M | 61 | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 34 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Thomas Miller
- Contatti personali
